Abstract
Copyright: © 2014 Rogatsky E. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This week in San Diego, USA the Society for Lab Automation and Screening (SLAS) annual meeting and expo is taking place. This conference features 132 word class podium presentations and 400 poster presentations attracting experts from industry and academia, students, engineers and business leaders from around the World. This is only the third annual meeting, representing a relatively young and rapidly growing and developing field of automation for different laboratory workflows and processes, which is steadily replacing semi-automatic or manual methods. Initially, the complete automation of manufacturing processes was achieved in industry for various production lines. Next, automation has brought benefits to sterile environments, e.g. vaccine production and blood banks in order to minimize employee exposure to biological hazards, minimizing human error, and ensuring product purity and integrity. The next breakthrough of automation was in routine laboratory operations, such as immunoassays, crystallography, DNA screening/sequencing, cell culture and stem cells assays. Automation of immunoassays has allowed multiplexing (multiple parallel assays) using single source serum samples significantly speeding up analysis while enhancing sample integrity by eliminating multiple freeze thaw cycles, and/or reducing sample requirements by reformatting from a single source sample. ELISA and other plate based immunoassay are the most frequently used assays in clinical diagnostics. They allow fast, relatively specific and sensitive assays of many analytes or metabolites. A workflow bottleneck for immunoassays is a typical incubation time of several hours, that makes the processing throughput of manual processing relatively slow only a few plates per day per lab technician. Automation of plate based assays, which has matured over the past few years has increased the productivity of clinical laboratories, decreased operational costs, minimized (human) errors, while enhancing workplace safety for laboratory personnel.
Highlights
Eduard Rogatsky* Biomarker Analytical Resource Core, Einstein-Montefiore Institute for Clinical and Translational Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA
This limitation has been steadily overcome, and as a result, lab automation is capable of facilitating progress in high throughput technologies in the fields of drug discovery, drug target biology, informatics, biomarker research, molecular diagnostics, bio-analytical chemistry and high throughput screening
The most challenging area in applying automation processes in bio-analytical chemistry is in the area of liquid chromatography combined with mass spectrometry analysis (LC/MS)
Summary
Eduard Rogatsky* Biomarker Analytical Resource Core, Einstein-Montefiore Institute for Clinical and Translational Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA This is only the third annual meeting, representing a relatively young and rapidly growing and developing field of automation for different laboratory workflows and processes, which is steadily replacing semi-automatic or manual methods. Automation of plate based assays, which has matured over the past few years has increased the productivity of clinical laboratories, decreased operational costs, minimized (human) errors, while enhancing workplace safety for laboratory personnel.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of Chromatography & Separation Techniques
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.